Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
OTTAWA, July 11, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), is pleased to announce that its wholly owned subsidiary Panag Pharma Inc. has...
-
ORLEANS, Ontario, July 05, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") a bio-pharmaceutical multifaceted corporation with its primary focus in cannabinoid‑based...
-
OTTAWA, June 18, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with...
-
U.S. granted patent protection for ophthalmic use;U.S. granted patent protection for topical delivery, increased drug solubility and abuse deterrence;U.S. FDA provides positive response on painful dry...
-
OTTAWA, June 17, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (“Tetra” or the “Company”) a leader in cannabinoid-derived drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF) today...
-
OTTAWA, June 11, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc., a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), today announced completion of Panag 001,...
-
OTTAWA, May 30, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company"), a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), will...
-
OTTAWA, May 14, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company"), a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today...
-
OTTAWA, May 09, 2019 (GLOBE NEWSWIRE) -- PANAG Pharma Inc. (PANAG), a wholly owned subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), a bio-pharmaceutical...
-
OTTAWA, May 02, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc. (Panag), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), today announced that its pilot...